Predictive Approaches in Drug Discovery and Development
Biomarkers and In Vitro / In Vivo Correlations
Published on 14. February 2012
368 pages
978-1-118-23026-8 (ISBN)
Description
Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers. Case histories and lessons from successful and unsuccessful applications of biomarkers are included along with key chapters on GLP validation, safety biomarkers and proteomics biomarkers. Regulatory agency perspectives and initiatives both in the US and internationally are also discussed.
Reviews / Votes
"The ability to correlate in vitro and in vivo biomarkerinformation in the process of drug discovery and development liesat the heart of translational research. The goal is to rapidlytranslate basic discoveries into clinical applications. This bookprovides state-of-the-art information on this exciting new researchapproach." (Doody's, 8 February 2013) "The text is packed with interesting, comprehensive, andpertinent information, clearly presented with salient pointsreinforced by inclusion in text boxes . . . This is an admirabletextbook for those dealing with drug discovery and development. Ienjoyed reading through it and I would recommend it to anyone whohas an interest, or is developing an interest, in the field ofbiomarkers and their, as yet, unfulfilled potential." (ISSX International Society for the Study of Xenobiotics, 1December 2012)More details
Other editions
Additional editions
J. Andrew Williams | Richard Lalonde | Jeffrey R. Koup
Predictive Approaches in Drug Discovery and Development
Biomarkers and In Vitro / In Vivo Correlations
Book
04/2012
Wiley
€154.50
Shipment within 10-20 days
JA Williams
Predictive Approaches in Drug Discovery and Develo pment: Biomarkers and In Vitro / In Vivo Correlati ons
Software
02/2012
Wiley
€127.14
Shipment within 15-20 days
Persons
J. Andrew Williams, PHD, is Director of Translational Oncologyat Pfizer Oncology.
Richard Lalonde, PharmD, is Vice President and Global Head ofClinical Pharmacology at Pfizer.
Jeffrey Koup, PharmD, is a consultant for PKPD modeling and theowner of Lakeside PKPD, LLC.
David D. Christ, PHD, is a consultant with SNC Partners LLC.
Content
PREFACE xi
ACKNOWLEDGMENTS xiii
CONTRIBUTORS xv
PART I BIOMARKERS IN DRUG DISCOVERY 1
1 The Importance of Biomarkers in Translational Medicine3
Joseph C. Fleishaker
2 Validation of Biochemical Biomarker Assays used in DrugDiscovery and Development: A Review of Challenges and Solutions23
Gabriella Szekely-Klepser and Scott Fountain
3 Proteomic Methods to Develop Protein Biomarkers 49
Ruth A. VanBogelen and Diane Alessi
4 Overview of Metabolomics Basics 79
Qiuwei Xu and William H. Schaefer
PART II CLINICAL APPLICATION OF BIOMARKERS 139
5 Vascular Biomarkers and Imaging Studies 141
Karin Potthoff, Ulrike Fiedler, and Joachim Drevs
6 Cardiovascular Biomarkers as Examples of Success andFailure in Predicting Safety in Humans 163
Simon Authier, Michael K. Pugsley, Eric Troncy, and MichaelJ. Curtis
7 The Use of Molecular Imaging for Receptor OccupancyDecision Making in Drug Development 189
Ralph Paul Maguire
8 Biosensors for Clinical Biomarkers 203
Sara Tombelli and Marco Mascini
PART III REGULATORY PERSPECTIVES 229
9 Regulatory Perspectives on Biomarker Development 231
Rajanikanth Madabushi, Lawrence Lesko, and JanetWoodcock
10 Perspectives from the European Regulatory Authorities255
Ian Hudson
11 Use of Biomarker in Drug Development--Japanese
Perspectives 269 Yoshiaki Uyama, Akihiro Ishiguro, HarumasaNakamura,and Satoshi Toyoshima
PART IV PREDICTING IN VIVO 289
12 In Vitro-In Vivo Correlations ofHepatic Drug Clearance 291
R. Scott Obach
13 The Potential of In Silico and In VitroApproaches to Predict In Vivo Drug-Drug Interactionsand ADMET/TOX Properties 307
Kenneth Bachmann and Sean Ekins
14 In Vitro-In Vivo Correlations in DrugDiscovery and Development: Concepts and Applications in Toxicology331
Rex Denton, Kimberly Brannen, and Bruce D. Car
15 Assessing the Potential for Induction of CytochromeP450 Enzymes and Predicting the In Vivo Response353
Jiunn H. Lin
INDEX 383
